Published in Nucleic Acids Res on November 25, 1992
tRNA(2Gln) mutants that translate the CGA arginine codon as glutamine in Escherichia coli. RNA (1998) 0.85
RNA stem-loop enhanced expression of previously non-expressible genes. Nucleic Acids Res (2004) 0.83
In vitro suppression as a tool for the investigation of translation initiation. Nucleic Acids Res (1997) 0.81
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science (1988) 220.77
Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science (1985) 95.08
Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res (1984) 86.56
Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene (1989) 60.30
An efficient mRNA-dependent translation system from reticulocyte lysates. Eur J Biochem (1976) 46.42
Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene (1989) 23.74
Fluorographic detection of radioactivity in polyacrylamide gels with the water-soluble fluor, sodium salicylate. Anal Biochem (1979) 22.03
Complementary DNA sequencing: expressed sequence tags and human genome project. Science (1991) 19.42
The "megaprimer" method of site-directed mutagenesis. Biotechniques (1990) 11.92
Amplification and analysis of DNA sequences in single human sperm and diploid cells. Nature (1988) 10.84
Human beta-globin pre-mRNA synthesized in vitro is accurately spliced in Xenopus oocyte nuclei. Cell (1983) 9.77
Nucleotide sequence of the E coli gene coding for dihydrofolate reductase. Nucleic Acids Res (1980) 8.75
Insertion mutagenesis to increase secondary structure within the 5' noncoding region of a eukaryotic mRNA reduces translational efficiency. Cell (1985) 7.95
Genomic amplification with transcript sequencing. Science (1988) 7.52
A simple method for site-directed mutagenesis using the polymerase chain reaction. Nucleic Acids Res (1989) 6.78
5'-terminal cap structure in eucaryotic messenger ribonucleic acids. Microbiol Rev (1980) 6.14
Access to a messenger RNA sequence or its protein product is not limited by tissue or species specificity. Science (1989) 4.48
A general method for site-specific incorporation of unnatural amino acids into proteins. Science (1989) 4.15
mRNA cap binding proteins: essential factors for initiating translation. Cell (1985) 4.07
The polymerase chain reaction. Trends Genet (1989) 3.95
Use of polymerase chain reaction catalyzed by Taq DNA polymerase for site-specific mutagenesis. Gene (1989) 3.11
A continuous cell-free translation system capable of producing polypeptides in high yield. Science (1988) 2.54
Nucleic acid amplification in vitro: detection of sequences with low copy numbers and application to diagnosis of human immunodeficiency virus type 1 infection. Clin Microbiol Rev (1989) 2.43
Message amplification phenotyping (MAPPing): a technique to simultaneously measure multiple mRNAs from small numbers of cells. Biotechniques (1990) 2.22
Overproduction and dissection of proteins by the expression-cassette polymerase chain reaction. Proc Natl Acad Sci U S A (1990) 1.77
A rapid method for site-specific mutagenesis and directional subcloning by using the polymerase chain reaction to generate recombinant circles. Biotechniques (1990) 1.49
A biochemical perspective of the polymerase chain reaction. Biochemistry (1991) 1.49
Effect of a single amino acid substitution on Escherichia coli dihydrofolate reductase catalysis and ligand binding. J Biol Chem (1981) 1.39
Site-specific incorporation of novel backbone structures into proteins. Science (1992) 1.36
Functions of the 5,-terminal m7G cap in eukaryotic mRNA. FEBS Lett (1978) 1.30
Dihydrofolate reductase hysteresis and its effect of inhibitor binding analyses. Biochemistry (1981) 1.26
The polymerase chain reaction: an improved method for the analysis of nucleic acids. Hum Genet (1989) 1.25
DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites. Proc Natl Acad Sci U S A (1990) 1.20
T4 RNA ligase mediated preparation of novel "chemically misacylated" tRNAPheS. Biochemistry (1984) 1.15
Mischarging Escherichia coli tRNAPhe with L-4'-[3-(trifluoromethyl)-3H-diazirin-3-yl]phenylalanine, a photoactivatable analogue of phenylalanine. Biochemistry (1988) 1.14
Dihydrofolate reductase. Purification and characterization of the enzyme from an amethopterin-resistant mutant of Escherichia coli. Biochemistry (1972) 1.08
Preparation of misacylated aminoacyl-tRNA(Phe)'s useful as probes of the ribosomal acceptor site. Biochemistry (1989) 0.88
Catalytic mechanism of the dihydrofolate reductase reaction as determined by pH studies. Biochemistry (1984) 0.88
Formation of active diphtheria toxin in vitro based on ligated fragments of cloned mutant genes. J Biol Chem (1989) 0.85
Escherichia coli tryptophan synthase: synthesis of catalytically competent alpha subunit in a cell-free system containing preacylated tRNAs. Biochemistry (1987) 0.78
Expression vector pT7:TKII for the synthesis of authentic biologically active RNA encoding vaccinia virus thymidine kinase. Gene (1989) 0.78
Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature (1997) 13.77
Eukaryotic mRNA cap binding protein: purification by affinity chromatography on sepharose-coupled m7GDP. Proc Natl Acad Sci U S A (1979) 2.81
gamma Ray induced deoxyribonucleic acid strand breaks. 3' Glycolate termini. J Biol Chem (1983) 2.41
Isolation and identification of four cytokinins from wheat germ transfer ribonucleic acid. Biochemistry (1970) 2.30
Cytokinins: synthesis, mass spectra, and biological activity of compounds related to zeatin. Proc Natl Acad Sci U S A (1969) 2.30
Structure of the mouse klotho gene and its two transcripts encoding membrane and secreted protein. FEBS Lett (1998) 2.15
Establishment of the anti-Klotho monoclonal antibodies and detection of Klotho protein in kidneys. Biochem Biophys Res Commun (2000) 2.11
In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome. Biochem Biophys Res Commun (2000) 1.97
On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex. Biochemistry (1989) 1.95
A cytoplasmic RNA vector derived from nontransmissible Sendai virus with efficient gene transfer and expression. J Virol (2000) 1.92
The effects of base analogue substitutions on the cleavage by the EcoRI restriction endonuclease of octadeoxyribonucleotides containing modified EcoRI recognition sequences. J Biol Chem (1986) 1.91
Molecular cloning and characterization of genes required for ribose transport and utilization in Escherichia coli K-12. J Bacteriol (1984) 1.76
Cytokinin from soluble RNA of Escherichia coli: 6-(3-methyl-2-butenylamino)-2-methylthio-9-beta-D-ribofuranosylpurine. Science (1968) 1.66
Evidence That More than 90% of beta-Glucuronidase-Expressing Cells after Particle Bombardment Directly Receive the Foreign Gene in their Nucleus. Plant Physiol (1991) 1.64
The effects of base analogue substitutions on the methylation by the EcoRI modification methylase of octadeoxyribonucleotides containing modified EcoRI recognition sequences. J Biol Chem (1986) 1.48
Palmar reconstruction of the triangular fibrocartilage complex for instability of the distal radioulnar joint: a biomechanical study. J Hand Surg Eur Vol (2012) 1.46
Ribonucleoside phosphates via phosphorimidazolidate intermediates. Synthesis of pseudoadenosine 5'-triphosphate. Biochemistry (1973) 1.40
Complication of adenoid cystic carcinoma and sialolithiasis in the submandibular gland: report of a case and its etiological background. Int J Oral Maxillofac Surg (2010) 1.39
Specificity of deoxyribonucleic acid cleavage by bleomycin, phleomycin, and tallysomycin. Biochemistry (1982) 1.36
Cytokinins: development of a potent antagonist. Proc Natl Acad Sci U S A (1971) 1.32
Intraoral grafting of an ex vivo produced oral mucosa equivalent: a preliminary report. Int J Oral Maxillofac Surg (2003) 1.28
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity. J Med Chem (1991) 1.28
CYTOKININS: SYNTHESIS OF 6-(3-METHYL-3-BUTENYLAMINO)-9-beta-D-RIBOFURANOSYLPURINE (3IPA), AND THE EFFECT OF SIDE-CHAIN UNSATURATION ON THE BIOLOGICAL ACTIVITY OF ISOPENTYLAMINOPURINES AND THEIR RIBOSIDES. Proc Natl Acad Sci U S A (1968) 1.26
Analysis of products formed during bleomycin-mediated DNA degradation. Biochemistry (1985) 1.22
The isolation and identification of two cytokinins from Escherichia coli transfer ribonucleic acids. Biochemistry (1969) 1.22
Cytokinin of wheat germ transfer RNA: 6-(4-hydroxy-3-methyl-2-butenylamino)-2-methylthio-9-beta-D-ribofuranosylpurine. Science (1969) 1.22
On the "activation" of cytokinins. J Biol Chem (1975) 1.22
Generation of packaging cell lines for pseudotyped retroviral vectors of the G protein of vesicular stomatitis virus by using a modified tetracycline inducible system. Proc Natl Acad Sci U S A (1996) 1.21
"Chemical aminoacylation" of tRNA's. J Biol Chem (1978) 1.19
The effect of "cap" analogs on reovirus mRNA binding to wheat germ ribosomes. Evidence for enhancement of ribosomal binding via a preferred cap conformation. J Biol Chem (1978) 1.18
Metal ion and substrate structure dependence of the processing of tRNA precursors by RNase P and M1 RNA. J Biol Chem (1990) 1.17
Chemical transformations of 7,9-disubstituted purines and related heterocycles. Selective reduction of imines and immonium salts. J Org Chem (1976) 1.16
Oligonucleotide N-alkylphosphoramidates: synthesis and binding to polynucleotides. Biochemistry (1988) 1.16
T4 RNA ligase mediated preparation of novel "chemically misacylated" tRNAPheS. Biochemistry (1984) 1.15
Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes. Clin Chem (2001) 1.14
Sendai virus-mediated CFTR gene transfer to the airway epithelium. Gene Ther (2007) 1.13
Site-specific cleavage of RNA by Fe(II).bleomycin. Proc Natl Acad Sci U S A (1990) 1.13
DNA sequence specificity of the pyrrolo[1,4]benzodiazepine antitumor antibiotics. Methidiumpropyl-EDTA-iron(II) footprinting analysis of DNA binding sites for anthramycin and related drugs. Biochemistry (1986) 1.12
Identification of 197 genetic variations in six human methyltranferase genes in the Japanese population. J Hum Genet (2001) 1.12
N 6 -( 2 -Isopentenyl)adenosine: the regulatory effects of a cytokinin and modified nucleoside from tRNA on human lymphocytes. Biochim Biophys Acta (1972) 1.11
FDG-PET findings in sclerosing hemangioma of the lung: a case report. Radiat Med (2001) 1.11
Chemistry of the alkali-labile lesion formed from iron(II) bleomycin and d(CGCTTTAAAGCG). Biochemistry (1988) 1.09
Iatrogenic gallbladder perforation during laparoscopic cholecystectomy: etiology and sequelae. Am Surg (1999) 1.04
Effects of release factor 1 on in vitro protein translation and the elaboration of proteins containing unnatural amino acids. Biochemistry (1999) 1.02
Structural studies of of "active complex" of bleomycin: assignment of ligands to the ferrous ion in a ferrous-bleomycin-carbon monoxide complex. Proc Natl Acad Sci U S A (1979) 1.01
Copper-dependent cleavage of DNA by bleomycin. Biochemistry (1987) 1.00
Amino acid substitutions in protein biosynthesis. Poly(A)-directed polyphenylalanine synthesis. J Biol Chem (1980) 1.00
A model for topoisomerase I-mediated insertions and deletions with duplex DNA substrates containing branches, nicks, and gaps. Biochemistry (1995) 0.99
Single nucleotide polymorphisms in the gene encoding Krüppel-like factor 7 are associated with type 2 diabetes. Diabetologia (2005) 0.99
Isolation and characterization of a novel gene encoding nuclear protein at a locus (D11S636) tightly linked to multiple endocrine neoplasia type 1 (MEN1). Hum Mol Genet (1994) 0.99
Use of COMPARE analysis to discover new natural product drugs: isolation of camptothecin and 9-methoxycamptothecin from a new source. J Nat Prod (2000) 0.99
Chemical modifications of transfer RNA species. Desulfurization with Raney nickel. Proc Natl Acad Sci U S A (1971) 0.99
Purification and cDNA cloning of cytokinin-specific binding protein from mung bean (Vigna radiata). Eur J Biochem (1998) 0.98
A chemical synthesis of adenosine 5'-(gamma-32P)triphosphate. Biochim Biophys Acta (1973) 0.98
Polynucleotide recognition and degradation by bleomycin. Prog Nucleic Acid Res Mol Biol (1994) 0.98
Control of the position of RNase P-mediated transfer RNA precursor processing. J Biol Chem (1990) 0.97
Isomeric phenylalanyl-tRNAs. Position of the aminoacyl moiety during protein biosynthesis. Proc Natl Acad Sci U S A (1974) 0.97
[Therapeutic and pathophysiologic consideration on diabetic microangiopathy from the view point of the blood rheology (author's transl)]. Horumon To Rinsho (1980) 0.96
5-Formyldeoxyuridine: a new type of DNA damage induced by ionizing radiation and its mutagenicity to salmonella strain TA102. Mutat Res (1990) 0.95
, Occolowitz J, Burrows WJ, Armstrong DJ, Skoog F, Bock RM, Gillam I, Tener GM: Cytokinins: isolation identification of 6-(3-methyl-2-butenylamino)-9-beta-D-ribyfuranosylpurine (2iPA) from yeast cysteine tRNA. Biochem Biophys Res Commun (1969) 0.95
A Mn2(+)-dependent ribozyme. Science (1990) 0.94
Cloning of a guanosine-inosine kinase gene of Escherichia coli and characterization of the purified gene product. J Bacteriol (1995) 0.94
A novel process of inosine 5'-monophosphate production using overexpressed guanosine/inosine kinase. Appl Microbiol Biotechnol (1997) 0.93
Characterization of iron (II).bleomycin-mediated RNA strand scission. Biochemistry (1993) 0.93
A signal sequence mutant defective in export of ribose-binding protein and a corresponding pseudorevertant isolated without imposed selection. EMBO J (1985) 0.93
Generation of a recombinant Sendai virus that is selectively activated and lyses human tumor cells expressing matrix metalloproteinases. Gene Ther (2004) 0.93
Cytokinins. Activity and identification in Staphylococcus epidermidis transfer ribonucleic acid. J Biol Chem (1970) 0.93
Magnetic materials in otoliths of bird and fish lagena and their function. Acta Otolaryngol (2001) 0.92
Identification of single-nucleotide polymorphisms (SNPs) of human N-acetyltransferase genes NAT1, NAT2, AANAT, ARD1 and L1CAM in the Japanese population. J Hum Genet (2001) 0.92
Improvement of multiple pathophysiological phenotypes of klotho (kl/kl) mice by adenovirus-mediated expression of the klotho gene. J Gene Med (2000) 0.92
Novel triterpenoids inhibit both DNA polymerase and DNA topoisomerase. Biochem J (2000) 0.92
DNA polymerase beta inhibitors from Sandoricum koetjape. J Nat Prod (1999) 0.92
Chemical modifications of transfer RNA species. Transfer RNA's terminating in 2'- and 3'-O-methyladenosine. Biochem Biophys Res Commun (1973) 0.91
Metallobleomycin-mediated cleavage of DNA not involving a threading-intercalation mechanism. J Am Chem Soc (2001) 0.91
Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex. Biochemistry (1999) 0.90
Expression and maturation of Sendai virus vector-derived CFTR protein: functional and biochemical evidence using a GFP-CFTR fusion protein. Gene Ther (2007) 0.90
Chemical and structural characterization of the interaction of bleomycin A2 with d(CGCGAATTCGCG)2. efficient, double-strand DNA cleavage accessible without structural reorganization. J Am Chem Soc (2001) 0.90
Dipeptide formation with misacylated tRNAPhes. J Biol Chem (1983) 0.90
Transient expression of beta-glucuronidase in Arabidopsis thaliana leaves and roots and Brassica napus stems using a pneumatic particle gun. Plant Mol Biol (1991) 0.90
Proton nuclear magnetic resonance study of the structure of bleomycin and the zinc-bleomycin complex. Biochemistry (1979) 0.90
Allelic loss on chromosome 9q is associated with lymph node metastasis of primary breast cancer. Jpn J Cancer Res (1998) 0.89
Anticytokinin activity of substituted pyrrolo[2,3-d]pyrimidines. Proc Natl Acad Sci U S A (1975) 0.89
A role for the metal binding domain in determining the DNA sequence selectivity of Fe-bleomycin. J Biol Chem (1990) 0.89
Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site. J Biol Chem (1990) 0.89
Competitive inhibition of beef heart cyclic AMP phosphodiesterase by cytokinins and related compounds. Proc Natl Acad Sci U S A (1974) 0.89
Chemical modifications of transfer rna species. Heavy atom derivatization of aminoacyl tRNA. Biochem Biophys Res Commun (1972) 0.88
Studies on the total synthesis of tallysomycin. Synthesis of the threonylbithiazole moiety containing a structurally unique glycosylcarbinolamide. Org Lett (2001) 0.88
There is a correlation between the DNA affinity and mutagenicity of several 3-amino-1-methyl-5H-pyrido[4,3-b]indoles. Proc Natl Acad Sci U S A (1980) 0.88
Preparation of misacylated aminoacyl-tRNA(Phe)'s useful as probes of the ribosomal acceptor site. Biochemistry (1989) 0.88
DNA damage and growth inhibition in cultured human cells by bleomycin congeners. Biochemistry (1985) 0.88
[Predictability of Gleason score and reduction time (tau) of prostatic volume after castration for the prognosis of prostatic cancer]. Nihon Hinyokika Gakkai Zasshi (1998) 0.88
Position of uridine thiation: the identification of minor nucleosides from transfer RNA by mass spectrometry. Biochim Biophys Acta (1969) 0.88
On the chemical nature of DNA and RNA modification by a hemin model system. Biochemistry (1990) 0.88
Metabolic activation of 1-methyl-3-amino-5H-pyrido[4,3-b]indole and several structurally related mutagens. Biochemistry (1981) 0.88
Deglyco-bleomycin. Degradation of DNA and formation of a structurally unique Fe(II) . CO complex. J Biol Chem (1982) 0.87
Probing the S1/S1' substrate binding pocket geometry of HIV-1 protease with modified aspartic acid analogues. Biochemistry (2000) 0.86
DNA damage induced by bleomycin in the presence of dibucaine is not predictive of cell growth inhibition. Biochemistry (1985) 0.86
DNA strand scission by activated bleomycin group antibiotics. Fed Proc (1986) 0.86
Plant anticancer agents, XXXIV. Cucurbitacins from Elaeocarpus dolichostylus. J Nat Prod (1985) 0.86